Characterization of a novel human BFL-1-specific monoclonal antibody
Lahiru Gangoda, Charis E Teh, Michael A Dengler, Sarah A Best, Clare E Weeden, Lin Tai, Erinna F Lee, Walter D Fairlie, Kate D Sutherland, Leonard C Harrison, Daniel H Gray, Andreas Strasser, Marco J Herold
CELL DEATH AND DIFFERENTIATION | NATURE PUBLISHING GROUP | Published : 2020
Awarded by Australian National Health and Medical Research Council (NHMRC)
Awarded by Leukemia and Lymphoma Society of America
Awarded by Cancer Council of Victoria
Awarded by Australian Government Independent Research Institute Infrastructure Support Scheme
We thank Dan Fayle, Krystal Hughes and Giovanni Siciliano for expert animal care. This work was supported by grants and fellowships from the Australian National Health and Medical Research Council (NHMRC) (Project Grants 1145728 to MJH, 1143105 to MJH and AS, 1122783 to APN, Program Grants 1016701 to AS and Fellowships 1020363 to AS, 1156095 to MJH) the Leukemia and Lymphoma Society of America (LLS SCOR 7001-13 to AS and MJH), the Cancer Council of Victoria (project grant 1052309 to AS and Venture Grant to MJH and AS) as well as by operational infrastructure grants through the Australian Government Independent Research Institute Infrastructure Support Scheme (361646 and 9000220) and the Victorian State Government Operational Infrastructure Support Program.